Guggenheim Capital’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.39M | Sell |
4,511
-4,726
| -51% | -$2.18M | 0.02% | 679 |
|
|
2026
Q1 | $4.44M | Buy |
9,237
+4,974
| +117% | +$2.55M | 0.03% | 475 |
|
|
2025
Q4 | $2.39M | Buy |
4,263
+1,301
| +44% | +$739K | 0.02% | 622 |
|
|
2025
Q3 | $1.52M | Sell |
2,962
-1,750
| -37% | -$764K | 0.01% | 777 |
|
|
2025
Q2 | $1.48M | Sell |
4,712
-211
| -4% | -$63.3K | 0.01% | 752 |
|
|
2025
Q1 | $1.5M | Sell |
4,923
-312
| -6% | -$105K | 0.01% | 723 |
|
|
2024
Q4 | $1.74M | Sell |
5,235
-2,414
| -32% | -$819K | 0.01% | 701 |
|
|
2024
Q3 | $2.55M | Buy |
7,649
+1,189
| +18% | +$452K | 0.02% | 742 |
|
|
2024
Q2 | $2.66M | Sell |
6,460
-9,412
| -59% | -$3.73M | 0.02% | 724 |
|
|
2024
Q1 | $6.41M | Buy |
15,872
+8,514
| +116% | +$2.99M | 0.05% | 470 |
|
|
2023
Q4 | $2.26M | Sell |
7,358
-985
| -12% | -$266K | 0.02% | 796 |
|
|
2023
Q3 | $2.02M | Sell |
8,343
-1,913
| -19% | -$489K | 0.02% | 808 |
|
|
2023
Q2 | $2.46M | Buy |
10,256
+478
| +5% | +$99.3K | 0.02% | 772 |
|
|
2023
Q1 | $1.84M | Sell |
9,778
-4,127
| -30% | -$854K | 0.02% | 880 |
|
|
2022
Q4 | $2.95M | Sell |
13,905
-2,577
| -16% | -$515K | 0.03% | 716 |
|
|
2022
Q3 | $2.59M | Sell |
16,482
-285
| -2% | -$45.5K | 0.02% | 744 |
|
|
2022
Q2 | $2.51M | Sell |
16,767
-896
| -5% | -$130K | 0.02% | 805 |
|
|
2022
Q1 | $2.89M | Sell |
17,663
-639
| -3% | -$105K | 0.02% | 867 |
|
|
2021
Q4 | $3.98M | Sell |
18,302
-4,835
| -21% | -$1.01M | 0.02% | 771 |
|
|
2021
Q3 | $4.38M | Sell |
23,137
-637
| -3% | -$116K | 0.03% | 716 |
|
|
2021
Q2 | $4.2M | Sell |
23,774
-2,671
| -10% | -$461K | 0.02% | 750 |
|
|
2021
Q1 | $4.34M | Sell |
26,445
-1,833
| -6% | -$280K | 0.03% | 694 |
|
|
2020
Q4 | $3.94M | Buy |
28,278
+16,339
| +137% | +$2.06M | 0.02% | 694 |
|
|
2020
Q3 | $1.33M | Buy |
11,939
+8,078
| +209% | +$934K | 0.01% | 1083 |
|
|
2020
Q2 | $359K | Buy |
+3,861
| New | +$329K | ﹤0.01% | 1544 |
|
|
2020
Q1 | – | Sell |
-4,268
| Closed | -$359K | – | 1942 |
|
|
2019
Q4 | $359K | Buy |
4,268
+128
| +3% | +$9.91K | ﹤0.01% | 1747 |
|
|
2019
Q3 | $348K | Sell |
4,140
-2,146
| -34% | -$162K | ﹤0.01% | 1786 |
|
|
2019
Q2 | $411K | Buy |
6,286
+128
| +2% | +$7.38K | ﹤0.01% | 1743 |
|
|
2019
Q1 | $363K | Sell |
6,158
-1,921
| -24% | -$115K | ﹤0.01% | 1830 |
|
|
2018
Q4 | $428K | Sell |
8,079
-17,342
| -68% | -$952K | ﹤0.01% | 1750 |
|
|
2018
Q3 | $1.52M | Buy |
+25,421
| New | +$1.39M | 0.01% | 1397 |
|
Other funds holding MEDP
WA
Guggenheim Capital's MEDP Position: Q2 2026 in Review
Guggenheim Capital reduced its Medpace (MEDP) stake by 51% in Q2 2026, selling an estimated $2.18M and leaving 4,511 shares worth $2.39M. The position accounts for 0.02% of the portfolio, ranked #679.
Guggenheim Capital first reported a position in MEDP in Q3 2018 and has held it in 31 quarters since. The position peaked at $6.41M in Q1 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Guggenheim Capital held 4,511 shares of Medpace worth $2.39M as of Q2 2026.
- Guggenheim Capital sold 4,726 Medpace shares in Q2 2026, an estimated $2.18M.
- Medpace made up 0.02% of Guggenheim Capital's portfolio in Q2 2026, its #679 holding.
- Guggenheim Capital first reported a position in Medpace in Q3 2018 and has held it in 31 quarters since.
- Guggenheim Capital's Medpace position peaked at $6.41M in Q1 2024.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.